Search Within

Anne S Reiner

Formats
  1. Journal Article (166)
  2. Meeting Abstract (70)
  3. Research Letter (7)
  4. Correspondence (2)
  5. Review (2)
  6. Editorial (1)
Groups
  1. Epidemiology and Biostatistics (174)
  2. Population Sciences Research Program (162)
  3. Biostatistics Service (153)
  4. Survivorship Research (82)
  5. Tow Center for Developmental Oncology (TCDO) (80)
  6. Epidemiology Service (64)

More Groups

People
  1. Katherine Panageas (90)
  2. Jonine Bernstein (46)
  3. Lisa De Angelis (39)
  4. Xiaolin Liang (36)
  5. Viviane Tabar (31)
  6. Irene Orlow (29)

More People

Years
  1. 2025 (9)
  2. 2024 (27)
  3. 2023 (22)
  4. 2022 (21)
  5. 2021 (17)
  6. 2020 (15)

More Years

Publications
  1. Neuro-Oncology (31)
  2. Journal of Clinical Oncology (21)
  3. Neuro-Oncology Advances (11)
  4. Neurosurgery (11)
  5. Journal of Neuro-Oncology (9)
  6. Cancer (8)

More Publications

Publishers
  1. Oxford University Press (55)
  2. American Society of Clinical Oncology (23)
  3. Elsevier Inc. (23)
  4. Springer (20)
  5. Wiley Blackwell (16)
  6. Wolters Kluwer (11)

More Publishers

Results (248)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic factors for glioblastoma (GBM) in individuals age 70 and older: A study of 446 patients from two tertiary centers
    Meeting Abstract

    Scott, J. G.; Chao, S. T.; Suh, J. H.; Cooper, A.; Reiner, A. S.; Nayak, L.; Panageas, K.; Abrey, L. E.; Iwamoto, F. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Immunomagnetic platform technology (IMPT) for the diagnosis of leptomeningeal metastasis in solid tumors (LMST)
    Meeting Abstract

    Nayak, L.; Fleisher, M.; Gonzalez-Espinoza, R.; Reiner, A. S.; Panageas, K.; Lin, O.; Liu, C.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Methotrexate (M) area under the curve (AUC) and creatinine clearance (CrCl) as prognostic factors in primary central nervous system lymphoma (PCNSL)
    Meeting Abstract

    Morris, P. G.; Abrey, L. E.; Reiner, A. S.; Panageas, K.; Seko, B.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)
    Meeting Abstract

    Khasraw, M.; Abrey, L. E.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Mellinghoff, I. K.; Reiner, A. S.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Is the difference in reexcision rate of various margin assessment methods due solely to difference in volume excised?
    Meeting Abstract

    Culpepper, C. K.; Goldberg, J. I.; Choi, L.; Brogi, E.; Sclafani, L.; King, T. A.; Heerdt, A. S.; Reiner, A. S.; Patil, S.; Van Zee, K. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Association of margin assessment method with reexcision rates in breast-conserving surgery (BCS)
    Meeting Abstract

    Choi, L.; Culpepper, C. K.; Goldberg, J. I.; Heerdt, A. S.; King, T. A.; Sclafani, L.; Reiner, A. S.; Patil, S.; Brogi, E.; Van Zee, K. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Prognostic significance of adrenal gland morphology at baseline CT in three common malignancies
    Meeting Abstract

    Meehan, C.; Fuqua, J.; Reiner, A.; Moskowitz, C.; Schwartz, L.; Panicek, D.
    American Journal of Roentgenology (2010)

    Fulltext@MSK | Save
  • Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2
    Journal Article

    Malone, K. E.; Begg, C. B.; Haile, R. W.; Borg, A.; Concannon, P.; Tellhed, L.; Xue, S. Y.; Teraoka, S.; Bernstein, L.; Capanu, M.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy
    Journal Article

    Rudloff, U.; Brogi, E.; Reiner, A. S.; Goldberg, J. I.; Brockway, J. P.; Wynveen, C. A.; McCormick, B.; Patil, S.; Van Zee, K. J.
    Annals of Surgery (2010)

    Fulltext@MSK | Save
  • Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
    Journal Article

    Reding, K. W.; Bernstein, J. L.; Langholz, B. M.; Bernstein, L.; Haile, R. W.; Begg, C. B.; Lynch, C. F.; Concannon, P.; Borg, A.; Teraoka, S. N.; more...
    Breast Cancer Research and Treatment (2010)

    Fulltext@MSK | Save